- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Imatron lands Malaysian CT order
Imatron has won an order for five of its ultrafast CT scanners from a medical investment group in Malaysia in an agreement that is worth $13 million over the next two-and-a-half years to the South San Francisco, CA, company. The Malaysian group is called
Imatron has won an order for five of its ultrafast CT scanners from a medical investment group in Malaysia in an agreement that is worth $13 million over the next two-and-a-half years to the South San Francisco, CA, company. The Malaysian group is called Heart Scan Malaysia, but is unaffiliated with Imatron or its HeartScan Imaging subsidiary. Heart Scan Malaysia intends to develop a network of ultrafast CT centers in the country to provide cardiac diagnostic services.
In other Imatron news, the company last month reported 1996 year-end financial results (end-December) that included a net loss of $10.5 million on revenues of $25.8 million. That compares with a net loss of $2.4 million on revenues of $26.7 million in 1995.
Imatron said its year-end loss included $4.6 million in losses associated with HeartScan Imaging, of which Imatron owns 49.5%. Imatron also reported that shipments for the first quarter of 1997 are up 33% over the same period last year.
Finally, Imatron reported this month that Rush-Presbyterian-St. Luke's Medical Center of Chicago has opened Rush Heart Scan, a new coronary heart disease diagnosis and treatment facility that is using an ultrafast CT scanner. Rush Heart Scan is not affiliated with Imatron's HeartScan Imaging subsidiary.
CT Study Reveals Key Indicators for Angiolymphatic Invasion in Non-Small Cell Lung Cancer
January 15th 2025In computed tomography (CT) scans for patients with solid non-small cell lung cancer (NSCLC) < 30 mm, emerging research suggests the lollipop sign is associated with a greater than fourfold likelihood of angiolymphatic invasion.
Can MRI-Based AI Enhance Risk Stratification in Prostate Cancer?
January 13th 2025Employing baseline MRI and clinical data, an emerging deep learning model was 32 percent more likely to predict the progression of low-risk prostate cancer (PCa) to clinically significant prostate cancer (csPCa), according to new research.
Shaping the Future of Radiology in 2025: Trends, Threats, and Opportunities
January 10th 2025How do we respond to challenges with staff recruitment, cybersecurity, and looming hospital takeovers in radiology? This author assesses key trends in radiology and offers key insights to stay competitive in the field.
